Flowable Gelatin Haemostatic Matrix Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드:1791224
리서치사:Lucintel
발행일:2025년 08월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 유동성 젤라틴 지혈재 시장의 장래성은 뇌신경외과, 산부인과, 정형외과, 일반외과, 이비인후과의 각 시장에서의 기회가 있어 유망시되고 있습니다. 세계의 유동성 젤라틴 지혈재 시장은 2025-2031년 CAGR 6.7%로 성장할 전망입니다. 이 시장의 주요 촉진요인은 저침습 수술에 대한 수요가 증가하고, 외상 치료에서 효과적인 지혈제에 대한 요구가 증가하고, 의료 용도에서 생물학적 유래 물질에 대한 선호도가 높아집니다.
Lucintel의 예측에서는 유형별로는 돼지 젤라틴이 예측 기간 중에 높은 성장을 이룰 전망입니다.
용도별로는 일반 수술이 가장 높은 성장이 예상됩니다.
지역별로는 북미가 예측 기간 동안 가장 높은 성장이 예상됩니다.
150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 얻을 수 있습니다.
유동성 젤라틴 지혈재 시장의 새로운 동향
유동성 젤라틴 지혈재 시장은 지혈 효과의 극대화, 취급 특성의 최적화, 임상 용도 확대를 목적으로 한 다양한 새로운 동향의 영향을 받고 있습니다.
효능 향상을 위한 활성 지혈제와의 조합 : 또 다른 중요한 동향은 유동성 젤라틴 지혈제와 트롬빈, 피브리노겐, 산화셀룰로오스와 같은 활성 지혈제와의 조합입니다. 이들은 시너지 효과를 제공하도록 설계되었으며, 특히 출혈이 어려운 상황에서 더 빠르고 효과적인 지혈을 제공합니다.
사용하기 쉬운 제품 설계 : 재구성이나 준비가 필요없는 즉시 사용할 수 있는 유동성 젤라틴 지혈재의 설계가 점점 더 중요해지고 있습니다. 이러한 제형은 편의성을 높이고 수술실의 시간을 단축하며 준비 실수의 가능성을 감소시킵니다.
감염 위험을 최소화하기 위한 항균제와의 병용 : 새로운 동향으로서 항균제와 유동성 젤라틴 지혈재료의 병용이 있습니다. 이것은 지혈과 동시에 수술 후 관리에 중요한 문제인 수술 부위 감염의 위험을 최소화하는 것을 목표로 합니다.
생분해성과 조직 통합 개선 : 유동성 젤라틴 지혈재의 생분해성을 극대화하고, 치유를 방해하거나 부작용을 유발하는 잔류물을 남기지 않고, 완전하게 흡수시키는 것을 목적으로 한 연구가 진행되고 있습니다. 조직 통합 강화도 주요 목표입니다.
주사 및 표적 전달 시스템 개발 : 주사 및 표적 전달 시스템 개발은 저침습적 방식으로 전달할 수 있거나 특수 도포기 및 카테터를 사용하여 특정 출혈 부위에 표적화할 수 있는 유동성 젤라틴 지혈재를 만들고 복강경 수술과 내시경 하수술에서의 사용을 더욱 증가시킵니다.
이러한 동향은 높은 지혈 성능, 보다 뛰어난 편의성, 보다 낮은 감염 리스크, 다수의 수술 전문 분야에 보다 폭넓은 적용성을 갖춘 제품을 위한 기술 혁신을 추진함으로써 유동성 젤라틴 지혈재 시장에 변화를 가져오고 있습니다. 병용 요법, 곧바로 사용할 수 있는 형태, 항균 활성, 생분해성의 최적화, 고도의 전달 시스템에 중점을 두는 것으로, 수술 결과의 향상과 환자의 보호를 도모하고 있습니다.
유동성 젤라틴 지혈재 시장의 최근 동향
유동성 젤라틴 지혈재 산업은 재료의 특성과 수술실에서의 사용을 극대화하는 것을 목표로 한 지속적인 연구를 특징으로 합니다.
고급 젤라틴 가공 방법 : 중요한 발전 중 하나는 최대 입자 크기, 다공성 및 팽윤 능력을 가진 지혈제를 생산하기 위한 젤라틴 가공의 개선입니다. 이러한 개선은 혈소판의 접착 및 응집을 위한 표면적을 증가시켜 보다 효율적인 지혈을 가능하게 합니다.
가교 젤라틴 지혈제의 개발 : 유동성 지혈재의 기계적 강도와 내열성을 개선하기 위해 젤라틴 분자의 가교도 연구되었습니다. 이는 특히 높은 유량 출혈에서 보다 지속적인 지혈을 가능하게 할 수 있습니다.
수술 중 시각화를 위한 이미징 에이전트 통합 : 한 기업은 유동성 젤라틴 지혈재에 이미징제를 통합하여 형광 이미징과 같은 방식으로 적용된 재료의 수술 중 시각화를 개선하고자 합니다.
조절된 팽윤 특성을 갖는 지혈제의 제조 : 유동성 젤라틴 지혈제가 최대로 팽윤하는 능력은 상처의 밀봉을 용이하게 하는 한편, 인접한 조직에 과도한 압력을 가하지 않도록 조절되어야 합니다. 진보를 통해 제어된 팽윤과 사전 프로그래밍된 팽윤에 대한 대응이 가능합니다.
인체공학에 근거한 정확한 전달 시스템의 도입 : 각 회사는 사용하기 쉬운 전달 시스템의 개발에 임하고 있어, 첨단이 가는 프리필드 애플리케이터를 포함해, 손이 닿기 어려운 장소에서도 출혈 부위에 유동성 젤라틴 지혈제를 정확하고 컨트롤하면서 도포할 수 있도록 하고 있습니다.
이러한 진보는 외과의사에게 빠르고 일관된 지혈을 위한 보다 효율적이고 다재다능한 편리한 기구를 제공함으로써 유동성 젤라틴 지혈재 시장에 큰 영향을 미칩니다. 최적화된 젤라틴 특성, 가교결합, 수술 중 시각화, 통제된 팽윤, 표적 전달이 중시되어 수술 성과와 환자의 안전성이 향상되었습니다.
목차
제1장 주요 요약
제2장 시장 개요
배경 및 분류
공급망
제3장 시장 동향 및 예측 분석
거시경제 동향 및 예측
업계의 촉진요인 및 과제
PESTLE 분석
특허 분석
규제 환경
제4장 세계의 유동성 젤라틴 지혈재 시장 : 유형별
개요
유형별 매력 분석
돼지 젤라틴 : 동향 및 예측(2019-2031년)
소 젤라틴 : 동향 및 예측(2019-2031년)
제5장 세계의 유동성 젤라틴 지혈재 시장 : 용도별
개요
용도별 매력 분석
뇌신경외과 : 동향 및 예측(2019-2031년)
산부인과 : 동향 및 예측(2019-2031년)
정형외과 : 동향 및 예측(2019-2031년)
일반 외과 : 동향 및 예측(2019-2031년)
이비인후과 : 동향 및 예측(2019-2031년)
기타 : 동향 및 예측(2019-2031)
제6장 지역별 분석
개요
지역별 세계의 유동성 젤라틴 지혈재 시장
제7장 북미의 유동성 젤라틴 지혈재 시장
개요
북미의 유동성 젤라틴 지혈재 시장 : 유형별
북미의 유동성 젤라틴 지혈재 시장 : 용도별
미국의 유동성 젤라틴 지혈재 시장
멕시코의 유동성 젤라틴 지혈재 시장
캐나다의 유동성 젤라틴 지혈재 시장
제8장 유럽의 유동성 젤라틴 지혈재 시장
개요
유럽의 유동성 젤라틴 지혈재 시장 : 유형별
유럽의 유동성 젤라틴 지혈재 시장 : 용도별
독일의 유동성 젤라틴 지혈재 시장
프랑스의 유동성 젤라틴 지혈재 시장
스페인의 유동성 젤라틴 지혈재 시장
이탈리아의 유동성 젤라틴 지혈재 시장
영국의 유동성 젤라틴 지혈재 시장
제9장 아시아태평양의 유동성 젤라틴 지혈재 시장
개요
아시아태평양의 유동성 젤라틴 지혈재 시장 : 유형별
아시아태평양의 유동성 젤라틴 지혈재 시장 : 용도별
일본의 유동성 젤라틴 지혈재 시장
인도의 유동성 젤라틴 지혈재 시장
중국의 유동성 젤라틴 지혈재 시장
한국의 유동성 젤라틴 지혈재 시장
인도네시아의 유동성 젤라틴 지혈재 시장
제10장 기타 지역의 유동성 젤라틴 지혈재 시장
개요
기타 지역의 유동성 젤라틴 지혈재 시장 : 유형별
기타 지역의 유동성 젤라틴 지혈재 시장 : 용도별
중동의 유동성 젤라틴 지혈재 시장
남미의 유동성 젤라틴 지혈재 시장
아프리카의 유동성 젤라틴 지혈재 시장
제11장 경쟁 분석
제품 포트폴리오 분석
운영 통합
Porter's Five Forces 분석
경쟁 기업간 경쟁 관계
구매자의 협상력
공급기업의 협상력
대체품의 위협
신규 참가업체의 위협
시장 점유율 분석
제12장 기회 및 전략 분석
밸류체인 분석
성장 기회 분석
유형별 성장 기회
용도별 성장 기회
세계 유동성 젤라틴 지혈재 시장에서의 새로운 동향
전략 분석
신제품 개발
인증 및 라이선싱
합병, 인수, 계약, 제휴 및 합작 사업
제13장 밸류체인에서 주요 기업의 기업 프로파일
경쟁 분석
Ferrosan Medical Devices
Baxter
Aegis Lifesciences
Pfizer
Jiangxi Boenrui
Beijing Nashi Biosurgery
Shenzhen HUANOVA
제14장 부록
List of Figures
List of Tables
Research Methodology
Disclaimer
Copyright
Abbreviations and Technical Units
About Us
Contact Us
AJY
영문 목차
영문목차
The future of the global flowable gelatin haemostatic matrix market looks promising with opportunities in the neurosurgery, obstetrics & gynecology, orthopedic, general surgery, and otolaryngology markets. The global flowable gelatin haemostatic matrix market is expected to grow with a CAGR of 6.7% from 2025 to 2031. The major drivers for this market are the rising demand for minimally invasive surgeries, the growing need for effective hemostatic agents in trauma care, and the increasing preference for biologically-derived materials in medical applications.
Lucintel forecasts that, within the type category, porcine gelatin is expected to witness higher growth over the forecast period.
Within the application category, general surgery is expected to witness the highest growth.
In terms of region, North America is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Flowable Gelatin Haemostatic Matrix Market
The flowable gelatin haemostatic matrix market is influenced by various emerging trends that are aimed at maximizing their haemostatic effectiveness, optimizing their handling characteristics, and extending their clinical applications.
Combination with Active Hemostatic Agents to Improve Efficacy: Another important trend involves the combination of flowable gelatin matrices with active haemostatic agents including thrombin, fibrinogen, or oxidized cellulose. These are designed to impart synergistic action, resulting in more rapid and effective hemostasis, especially in difficult bleeding situations.
Design of Ready-to-Use Products for Easy Application: An increased emphasis exists on designing ready-to-use flowable gelatin haemostatic matrices that make reconstitution or preparation unnecessary. Such formulations enhance convenience, shorten operating room time, and lower the potential for preparation mistakes.
Combination with Antimicrobial Agents to Minimize Infection Risk: A new trend is the combination of antimicrobial agents with flowable gelatin haemostatic matrices. This is intended to offer hemostasis while also minimizing the risk of surgical site infection, an important issue in postoperative management.
Biodegradability and Tissue Integration Improvements: Research is aimed at maximizing the biodegradability of flowable gelatin matrices to allow full absorption without residual material that might hinder healing or induce adverse reactions. Enhanced tissue integration is also a primary target.
Injectable and Targeted Delivery System Development: Development of injectable and targeted delivery systems is a growing trend towards creating flowable gelatin haemostatic matrices that are deliverable by minimally invasive methods or targeted to the specific sites of bleeding using special applicators or catheters, further increasing their use in laparoscopic and endoscopic surgery.
These trends are transforming the flowable gelatin haemostatic matrix market by propelling innovation towards products with greater haemostatic performance, better convenience, lower risk of infection, and broader applicability to multiple surgical specialties. The emphasis on combination therapy, ready-to-use presentation, antimicrobial activity, biodegradability optimization, and sophisticated delivery systems is directed at enhancing surgical results and patient protection.
Recent Developments in the Flowable Gelatin Haemostatic Matrix Market
The flowable gelatin haemostatic matrix industry is marked by continuous research aimed at maximizing the material properties and usage in operating rooms.
Advanced Gelatin Processing Methods: One of the important advancements is improvements in the processing of gelatin to produce matrices with maximum particle size, porosity, and swelling capacity. Such refinement results in increased surface area for platelet adhesion and aggregation, thus providing more efficient hemostasis.
Cross-Linked Gelatin Matrix Development: Cross-linking of gelatin molecules is also being investigated to improve the mechanical strength and resistance to degradation of flowable haemostatic matrices. This has the potential to deliver more sustained hemostasis, especially in high-flow bleeding.
Imaging Agent Integration for Intraoperative Visualization: Certain companies are exploring the integration of imaging agents into flowable gelatin haemostatic matrices to enable improved intraoperative visualization of the material applied using methods such as fluorescence imaging.
Production of Matrices with Regulated Swelling Character: The ability of flowable gelatin haemostatic matrices to swell to a maximum requires regulation so as not to build up too much pressure on contiguous tissues while facilitating sealing of wounds. Advances address controlled and pre-programmed swelling.
Introduction of Ergonomic and Accurate Delivery Systems: Companies are working towards the development of easy-to-use delivery systems, including pre-filled applicators with fine tips, enabling accurate and controlled application of the flowable gelatin matrix at the site of bleeding, even in hard-to-reach locations.
These advancements are profoundly affecting the flowable gelatin haemostatic matrix market by offering surgeons more efficient, versatile, and convenient instruments for rapid and consistent hemostasis. The emphasis on optimized gelatin characteristics, cross-linking, intraoperative visualization, controlled swelling, and targeted delivery leads to enhanced surgical outcomes and patient safety.
Strategic Growth Opportunities in the Flowable Gelatin Haemostatic Matrix Market
The flowable gelatin haemostatic matrix market provides some strategic growth opportunities through many of the major surgical applications.
Cardiovascular Surgery: The requirement for efficient and biocompatible haemostatic agents in complicated cardiovascular procedures, such as cardiac and vascular surgeries, is a strong growth opportunity for flowable gelatin haemostatic matrices, especially those with active agents.
Orthopedic Surgery: Maintenance of hemostasis in orthopedic operations, particularly during large joint arthroplasties and spine surgery, is important. The flowable gelatin matrices have a useful place in controlling oozing hemorrhage in such situations and pose a large growing opportunity.
Neurosurgery: Hemostasis in refined neurosurgical interventions demands highly biocompatible materials with favorable application ease. Flowable gelatin matrices pose an effective, safe solution to haemostatic bleeding control within the central nervous system, identifying a major opportunity for growth.
General Surgery and Trauma: The wide variety of general surgical procedures and trauma cases commonly present with major bleeding. Flowable gelatin haemostatic matrices offer a general-purpose solution to achieve hemostasis quickly in these varied situations, offering a huge growth opportunity.
Minimally Invasive Surgery (MIS): Growing use of MIS technologies, including laparoscopy and endoscopy, generates a need for haemostatic products that will be easily delivered via small incisions or endoluminal lumen. Flowable gelatin matrices with sophisticated delivery systems are particularly suited for these uses, providing a major opportunity for growth.
Seizing these strategic growth opportunities necessitates that manufacturers create flowable gelatin haemostatic matrices that are customized to meet the unique demands of each surgical specialty. This involves optimizing the formulation, delivery system, and performance characteristics to meet the distinct challenges and needs of cardiovascular, orthopedic, neurosurgical, general, trauma, and minimally invasive surgeries.
Flowable Gelatin Haemostatic Matrix Market Driver and Challenges
The market for flowable gelatin haemostatic matrices is driven by a mix of factors that promote its use and pose some challenges to its growth and development.
The factors responsible for driving the flowable gelatin haemostatic matrix market include:
1. Growing Number of Surgical Procedures: The growing number of surgical procedures being conducted worldwide, fueled by an aging population and improved surgical techniques, directly boosts the demand for effective haemostatic agents such as flowable gelatin matrices.
2. Increasing Demand for Advanced Hemostatic Products: Surgeons are increasingly demanding advanced haemostatic products that provide quick, consistent, and biocompatible bleeding control over conventional techniques, fueling the use of flowable gelatin matrices.
3. Multifaceted Use Across Different Surgical Specialties: The versatility of flowable gelatin haemostatic matrices in being used across a wide variety of surgical specialties such as cardiovascular, orthopedic, neurosurgery, and general surgery supports their high market demand.
4. Friendly Biocompatibility and Safety Profile: Gelatin is a biocompatible and natural material with an established safety profile, and flowable gelatin matrices are hence a popular choice among surgeons worried about tissue reaction and long-term consequences.
5. Sustained Product Development and Innovation: Active development and research activities aimed at improving the efficacy, workability, and use of flowable gelatin matrices are resulting in better products and increasing their clinical applications.
Challenges in the flowable gelatin haemostatic matrix market are:
1. Competition from Other Advanced Hemostatic Agents: The market for flowable gelatin haemostatic matrices is competitively challenged by other advanced haemostatic products, including oxidized regenerated cellulose, collagen hemostats, and synthetic sealants, which can provide various benefits in certain surgical contexts.
2. Cost Considerations in Healthcare Systems: The price of advanced haemostatic agents, such as flowable gelatin matrices, can be a major determinant, especially in cost-sensitive markets or in those healthcare systems with limited budgets.
3. Proper Training and Usage Protocols: Proper training of surgical personnel on preparation and application methods is crucial for the successful application of flowable gelatin haemostatic matrices to achieve optimal hemostasis with minimal complications.
The rising number of surgical procedures, the increased demand for sophisticated haemostatic products, and the versatility and beneficial biocompatibility of flowable gelatin matrices are prime drivers behind the expansion of this market. Continuous product development further adds to their attractiveness. Nevertheless, competition from other haemostatic agents, economic factors, and the requirement for adequate training create challenges that need to be met by manufacturers and healthcare professionals in order to provide continued and universal acceptance of flowable gelatin haemostatic matrices in surgery.
List of Flowable Gelatin Haemostatic Matrix Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, flowable gelatin haemostatic matrix companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the flowable gelatin haemostatic matrix companies profiled in this report include:
Ferrosan Medical Devices
Baxter
Aegis Lifesciences
Pfizer
Jiangxi Boenrui
Beijing Nashi Biosurgery
Shenzhen HUANOVA
Flowable Gelatin Haemostatic Matrix Market by Segment
The study includes a forecast for the global flowable gelatin haemostatic matrix market by type, application, and region.
Flowable Gelatin Haemostatic Matrix Market by Type [Value from 2019 to 2031]:
Porcine Gelatin
Bovine Gelatin
Flowable Gelatin Haemostatic Matrix Market by Application [Value from 2019 to 2031]:
Neurosurgery
Obstetrics & Gynecology
Orthopedics
General Surgery
Otolaryngology
Others
Flowable Gelatin Haemostatic Matrix Market by Region [Value from 2019 to 2031]:
North America
Europe
Asia Pacific
The Rest of the World
Country Wise Outlook for the Flowable Gelatin Haemostatic Matrix Market
The flowable gelatin haemostatic matrix market industry is a major area of surgical hemostasis, providing a biocompatible and efficient option for the management of bleeding in a variety of surgical applications. Recent trends throughout the United States, China, Germany, India, and Japan represent a worldwide tendency towards increased efficacy, greater ease of handling, and increased usage. Gelatin processing innovations, the addition of adjunctive haemostatic agents, and developments in delivery systems are primary areas of interest. Market forces are also driven by the expanding number of surgical procedures and the growing need for advanced haemostatic products with fast and consistent bleeding control.
United States: The American market is noted for having a high rate of adoption of state-of-the-art haemostatic technologies and strong product innovation. Some of the recent advances have been the launch of flowable gelatin matrices with improved swelling ability for greater wound sealing and the addition of thrombin or other clotting factors to speed up hemostasis. An emphasis has also been placed on creating products that are simple to prepare and use in a wide range of surgery.
China: The Chinese market is seeing tremendous growth in the medical device market, including haemostatic devices. Recent news includes the expanding domestic production of flowable gelatin matrices, frequently at lower prices. In addition, there is a focus on enhancing the quality and effectiveness of these locally produced products to address the needs of a fast-growing healthcare system.
Germany: Highly technologically advanced in medicine, Germany has a trend in advanced flowable gelatin haemostatic matrices with defined performance attributes and biocompatibility. Some of the recent advancements include gelatin particle size and distribution optimization for increased surface area and clotting rate. User-friendly packaging and delivery forms as well as exact application are also emphasized.
India: The Indian market is experiencing growing acceptance of newer surgical techniques and rising demand for efficient haemostatic agents. Recent trends have been the increasing availability of flowable gelatin matrices from both domestic and foreign suppliers. Increasing emphasis is also being placed on cost-effective products that offer consistent hemostasis in a variety of surgical specialties.
Japan: Japan's market is focusing on high-quality and safety considerations in medical devices. Some new developments include introducing flowable gelatin haemostatic matrices that have improved biodegradability and low tissue reaction. Also emphasized are products that provide immediate and sustained hemostasis to lead to enhanced surgical outcomes as well as minimized postoperative complications.
Features of the Global Flowable Gelatin Haemostatic Matrix Market
Market Size Estimates: Flowable gelatin haemostatic matrix market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Flowable gelatin haemostatic matrix market size by type, application, and region in terms of value ($B).
Regional Analysis: Flowable gelatin haemostatic matrix market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the flowable gelatin haemostatic matrix market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the flowable gelatin haemostatic matrix market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the flowable gelatin haemostatic matrix market by type (porcine gelatin and bovine gelatin), application (neurosurgery, obstetrics & gynecology, orthopedics, general surgery, otolaryngology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain
3. Market Trends & Forecast Analysis
3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment
4. Global Flowable Gelatin Haemostatic Matrix Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Porcine Gelatin: Trends and Forecast (2019-2031)
4.4 Bovine Gelatin: Trends and Forecast (2019-2031)
5. Global Flowable Gelatin Haemostatic Matrix Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Neurosurgery: Trends and Forecast (2019-2031)
5.4 Obstetrics & Gynecology: Trends and Forecast (2019-2031)
5.5 Orthopedics: Trends and Forecast (2019-2031)
5.6 General Surgery: Trends and Forecast (2019-2031)
5.7 Otolaryngology: Trends and Forecast (2019-2031)
5.8 Others: Trends and Forecast (2019-2031)
6. Regional Analysis
6.1 Overview
6.2 Global Flowable Gelatin Haemostatic Matrix Market by Region
7. North American Flowable Gelatin Haemostatic Matrix Market
7.1 Overview
7.2 North American Flowable Gelatin Haemostatic Matrix Market by Type
7.3 North American Flowable Gelatin Haemostatic Matrix Market by Application
7.4 United States Flowable Gelatin Haemostatic Matrix Market
